Extended Reduced-Dose Apixaban for Cancer-Associated Venous Thromboembolism
Extended Reduced-Dose Apixaban for Cancer-Associated Venous Thromboembolism Isabelle Mahé, M.D.,…
Ler MaisHow to deal with interference on heparin anti-Xa activity caused by oral factor FXa inhibitors: communication from the ISTH SSC Subcommittee on Control of Anticoagulation
How to deal with interference on heparin anti-Xa activity caused…
Ler Mais